RECOMMENDATION 8. CSAT, in collaboration with state substance abuse authorities, professional organizations, and consumer organizations in the addiction field, should continue the development of evidence-based treatment recommendations for use by clinicians of all disciplines involved in the treatment of drug and alcohol use disorders.
To ensure that these treatment recommendations have a positive impact on health care, these agencies and groups should work to encourage their use. Measurement of the impact of guidelines on clinical care delivery will optimally include short-, intermediate-, and long-term treatment outcomes.
Consumers are rarely involved in the issues of how drug abuse treatment research is supported and conducted. Although many community-based treatment programs were founded by men and women in recovery and counselors in recovery make up a significant portion of the workforce, there are few advocacy groups for patients and their families. In view of the stigma and legal hazards attached to illicit drug abuse, the reluctance to advocate is understandable but unfortunate. Consumer advocacy for state-of-the-art services has improved care for individuals with cancer and with HIV/AIDS. Drug abuse treatment may enjoy similar benefits if drug treatment consumers become informed consumer advocates.
RECOMMENDATION 9. CSAT and NIDA, in collaboration with state substance abuse authorities, should develop public awareness programs to encourage consumers and their families to recognize high-quality treatment programs so they will begin to demand that treatment programs include research-proven treatment approaches within their treatment models.
There are a variety of approaches that can be considered by these groups to accomplish this goal. These include: